Market Tracker

05/26 9:46am ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

258.82
BATS BZX Real-Time Price
As of 9:44am ET
 -2.64 / -1.01%
Today’s Change
128.50
Today|||52-Week Range
349.08
+65.91%
Year-to-Date

Today’s Trading

Previous close261.46
Today’s open258.02
Day’s range257.70 - 260.00
Volume3,800
Average volume (3 months)651,141
Market cap$6.3B
Dividend yield--
Data as of 9:31am ET, 05/26/2015

Growth & Valuation

Earnings growth (last year)-262.50%
Earnings growth (this year)+34.86%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+7.40%
P/E ratioNM
Price/Sales1,861.70
Price/Book24.25

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...-0.41-0.21%
IDXXIDEXX Laboratories I...+0.28+0.20%
TAROTaro Pharmaceutical ...+0.48+0.34%
SGENSeattle Genetics Inc-0.26-0.60%
Data as of 9:46am ET, 05/26/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$1.78
Annual revenue (last year)$1.7M
Annual profit (last year)-$283.2M
Net profit margin-16,262.23%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer, Secretary &
Treasurer
Barbara Gayle Duncan
Corporate headquarters
New York, New York

Forecasts